Microvascular Obstruction in Acute Myocardial Infarction

1. Van’t Hof W, Liem A, de Boer J, et al. Zwolle Myocardial Infarction Study Group. Clini-cal value of 12-lead electrocardiogram after successful reperfusion therapy for acute myo-cardial infarction. Lancet. 1997;350:615-619.10.1016/S0140-6736(96)07120-6Search in Google Scholar

2. Resnic FS, Wainstein MW, Lee MK, et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J. 2003;145:42-46. doi: 10.1067/mhj.2003.36.10.1067/mhj.2003.36Open DOISearch in Google Scholar

3. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992;85:1699-1705.10.1161/01.CIR.85.5.1699Search in Google Scholar

4. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the ‘no-reflow’ phenome-non: A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223-228.10.1161/01.CIR.93.2.223Open DOISearch in Google Scholar

5. Eitel I, Wöhrle J, Suenkel H, et al. Intracoronary Compared With Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Cardiac Magnetic Resonance Substudy of the AIDA STEMI Trial. J Am Coll Cardiol. 2013;61:1447-1454. doi: 10.1016/j.jacc.2013.01.048.10.1016/j.jacc.2013.01.048Open DOISearch in Google Scholar

6. Jolly SS, Cairns JA, Yusuf S, et al. Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomized TOTAL trial. Lancet. 2015;387:127-135. doi: 10.1016/S0140-6736(15)00448-1.10.1016/S0140-6736(15)00448-1Open DOISearch in Google Scholar

7. Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005;293:1063-1072. doi: 10.1001/jama.293.9.1063.10.1001/jama.293.9.106315741528Open DOISearch in Google Scholar

8. Kelbaek H, Terkelsen CJ, Helqvist S, et al. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol. 2008;51:899-905. doi: 10.1016/j.jacc.2007.10.047.10.1016/j.jacc.2007.10.04718308157Search in Google Scholar

9. Soeda T, Higuma T, Abe N, et al. Morphological predictors for no reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture. Eur Heart J Cardiovasc Imaging. 2017;18:103-110. doi: 10.1093/ehjci/jev341.10.1093/ehjci/jev34126800769Open DOISearch in Google Scholar

10. Brener SJ, Dizon JM, Mehran R, et al. Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial. Am Heart J. 2013;166:676-683. doi: 10.1016/j.ahj.2013.07.025.10.1016/j.ahj.2013.07.02524093847Search in Google Scholar

11. De Lemos JA, Braunwald E. ST Segment Resolution as a Tool for Assessing the Efficacy of Reperfusion Therapy. J Am Coll Cardiol. 2001;38:1283-1294.10.1016/S0735-1097(01)01550-9Open DOISearch in Google Scholar

12. Iwakura K, Ito H, Takiuchi S, et al. Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction. Circulation. 1996;94:1269-1275.10.1161/01.CIR.94.6.12698822979Open DOISearch in Google Scholar

13. Okamura A, Ito H, Iwakura K, et al. Usefulness of a new grading system based on coronary flow velocity pattern in predicting outcome in patients with acute myocardial infarction having percutaneous coronary intervention. Am J Cardiol. 2005;96:927-932. doi: 10.1016/j.amjcard.2005.05.049.10.1016/j.amjcard.2005.05.04916188518Open DOISearch in Google Scholar

14. Iwakura K, Ito H, Kawano S, et al. Assessing myocardial perfusion with the transthoracic Doppler technique in patients with reperfused anterior myocardial infarction: comparison with angiographic, enzymatic and electrocardiographic indices. Eur Heart J. 2004;25:1526-1533. doi: 10.1016/j.ehj.2004.06.029.10.1016/j.ehj.2004.06.02915342172Open DOISearch in Google Scholar

15. Kramer MC, Van der Wal AC, Koch KT, et al. Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention. Circulation. 2008;118:1810-1816. doi: 10.1161/CIRCULATIONAHA.108.780734.10.1161/CIRCULATIONAHA.108.78073418852369Open DOISearch in Google Scholar

16. Schwartz RS, Burke A, Farb A, et al. Microemboli and Microvascular Obstruction in Acute Coronary Thrombosis and Sudden Coronary Death: Relation to Epicardial Plaque Histopathology. J Am Coll Cardiol. 2009;23:2167-2173. doi: 10.1016/j.jacc.2009.07.042.10.1016/j.jacc.2009.07.04219942088Open DOISearch in Google Scholar

17. Patel N, Petraco R, Dall'Armellina E, et al. Zero-Flow Pressure Measured Immediately After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Provides the Best Invasive Index for Predicting the Extent of Myocardial Infarction at 6 Months: An OxAMI Study (Oxford Acute Myocardial Infarction). J Am Coll Cardiol Intev. 2015;8:1410-1421. doi: 10.1016/j.jcin.2015.04.029.10.1016/j.jcin.2015.04.02926404192Search in Google Scholar

18. Sezer M, Umman B, Okcular I, Nisanci Y, Umman S. Relationship between microvascular resistance and perfusion in patients with reperfused acute myocardial infarction. J Interv Cardiol. 2007;20:340-350. doi: 10.1111/j.1540-8183.2007.00274.x.10.1111/j.1540-8183.2007.00274.x17880330Open DOISearch in Google Scholar

19. Echavarría-Pinto M, Serruys PW, Garcia-Garcia HM, et al. Use of intracoronary physiology indices in acute coronary syndromes. Interventional Cardiology. 2015;7:5,483-495.Search in Google Scholar

20. Westman PC, Lipinski MJ, Luger D, et al. Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction. J Am Coll Cardiol. 2016;67:2050-2060. doi: 10.1016/j.jacc.2016.01.073.10.1016/j.jacc.2016.01.07327126533Open DOISearch in Google Scholar

21. Qin T, Xie L and Chen MH. Meta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-reflow phenomenon. BMC Cardiovasc Disord. 2013;13:68. doi: 10.1186/1471-2261-13-68.10.1186/1471-2261-13-68384719524016038Open DOISearch in Google Scholar

22. Sezer M. Oflaz H, Gören T, et al. Intracoronary Streptokinase after Primary Percutaneous Coronary Intervention. N Engl J Med. 2007; 356:1823-1834. doi: 10.1056/NEJMoa054374.10.1056/NEJMoa05437417476008Open DOISearch in Google Scholar

23. Iancu A, Ober C, Bondor CI, Cadiş H. Microvascular effect of intracoronary eptifibatide in acute myocardial infarction. Cardiology. 2012;123:46-53. doi: 10.1159/000341197.10.1159/00034119722986471Open DOISearch in Google Scholar